id: NEW:insulin_sensitizer_treatment_to_obesity_individual
name: Insulin Sensitizer Treatment â†’ Obesity Individual
from_node:
  node_id: NEW:insulin_sensitizer_treatment
  node_name: Insulin Sensitizer Treatment
to_node:
  node_id: obesity_individual
  node_name: Obesity Individual
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: Insulin sensitizers administered to PCOS patients'
- 'Step 2: Improved insulin sensitivity reduces lipogenic effects of hyperinsulinemia'
- 'Step 3: Better metabolic regulation may support weight management'
- 'Step 4: BMI effects measured as treatment outcome'
evidence:
  quality_rating: A
  n_studies: 6
  primary_citation: 'Fabio Facchinetti et al. 2019. "Short-term effects of metformin and myo-inositol
    in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials.."
    https://doi.org/10.1080/09513590.2018.1540578'
  supporting_citations:
  - Additional citations require full-text access - meta-analysis included 6 RCTs comparing MET to MI
  - Studies conducted from 1994-2017 identified via MEDLINE, Cochrane Library, PubMed
  - Individual study citations available in full-text systematic review
  doi: 10.1080/09513590.2018.1540578
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: 'No significant difference between metformin and myo-inositol on BMI (SMD=-0.22, 95% CI:
  -0.60-0.16, p=.265), indicating equivalent short-term effects on body weight in PCOS women.'
quantitative_effects:
  effect_size:
    value: -0.22
    type: standardized_mean_difference
    ci_lower: -0.6
    ci_upper: 0.16
  p_value: 0.265
  sample_size: 355
structural_competency:
  equity_implications: While neither treatment shows superior BMI effects, the availability of a supplement-based
    option may improve treatment uptake and adherence, particularly in populations with limited healthcare
    access.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.987959'
  extraction_confidence: high
  prompt_version: 2.1-canonical-validated
